Form 10-Q PRICE T ROWE GROUP INC For: Jun 30
Tweet
Share
E-mail
http://archive.fast-edgar.com/20140724/AV2Z622CD22222Z2222P22XZM4SEZ2R23W62
Filed on: July 24, 2014
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- T. ROWE PRICE EXPLORES WHAT INTEL'S REINVENTION COULD SIGNAL FOR THE FUTURE OF AI INFRASTRUCTURE
- Verrica Pharmaceuticals Announces First U.S. Patient Dosed in the Second Pivotal Clinical Trial (COVE-3) of its Phase 3 Program Evaluating YCANTH® (VP-102) for the Treatment of Common Warts
- The Cataltheia Group and Bruno Vision Care Announce Publication of Landmark Clinical Study Validating Deseyne® Extended Depth of Focus Technology for Presbyopia
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
